scispace - formally typeset
S

Simona Iodice

Researcher at University of Milan

Publications -  64
Citations -  5349

Simona Iodice is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 23, co-authored 57 publications receiving 4551 citations. Previous affiliations of Simona Iodice include European Institute of Oncology & Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

Papers
More filters
Journal ArticleDOI

Tobacco smoking and cancer: A meta-analysis

Sara Gandini, +6 more
- 01 Jan 2008 - 
TL;DR: The analysis of heterogeneity showed that study type, gender and adjustment for confounding factors significantly influence the RRs estimates and the reliability of the studies, and pooled RRs for respiratory cancers were greater than the pooled estimates for other sites.
Journal ArticleDOI

Smoking and colorectal cancer: a meta-analysis.

Edoardo Botteri, +5 more
- 17 Dec 2008 - 
TL;DR: Cigarette smoking is significantly associated with colorectal cancer incidence and mortality, and the association was stronger for cancer of the rectum than of the colon.
Journal ArticleDOI

Tobacco and the risk of pancreatic cancer: a review and meta-analysis

Simona Iodice, +6 more
- 12 Jan 2008 - 
TL;DR: Based on estimates from four continents, smoking cigarettes causes a 75% increase in the risk of pancreatic cancer compared to non-smokers, and the risk persists for a minimum of 10 years after smoking cessation.
Journal ArticleDOI

Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies

Armin Zittermann, +5 more
- 01 Jan 2012 - 
TL;DR: Data suggest a nonlinear decrease in mortality risk as circulating 25(OH)D increases, with optimal concentrations ∼75-87.5 nmol/L.
Journal ArticleDOI

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, +11 more
- 03 Sep 2011 - 
TL;DR: 177Lu-DOTATATE was well tolerated up to 29 GBq cumulative activity and the maximum tolerated dose/cycle was not reached, however, considering the individual bone marrow function and the presence of risk factors for kidney toxicity, it seems safer to divide cumulative activities into lower activity cycles.